Phase 2 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old
- People who have been diagnosed with primary Sjögren's syndrome (a condition that affects the immune system, often causing dry eyes and dry mouth) according to recognised 2016 classification guidelines, OR people who have been diagnosed with a solid tumour (a type of cancer) and are already scheduled for a specific type of scan called a FAPI PET scan
Who may not be able to join:
- People in the Sjögren's syndrome group who also have cancer or another connective tissue disease (a group of conditions affecting the body's structural tissues)
- People in either group who are currently taking hormone treatments or biological medicines (a type of medication made from living cells)
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhaohui Zhu, MD, Peking Union Medical College Hospital
Phone: 13611093752
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Optimal imaging time; Correlation with inflammatory markers; Comparative uptake analysis between Sjögren's syndrome and tumor patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.